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background: The incidence of vascular complications associated with the use of large-diameter introducer sheaths in transfemoral (TF) 
transcatheter aortic valve replacement (TAVR) was up to 30% in the PARTNER trial. It is unclear how procedural strategies for obtaining femoral 
access affect these rates. We therefore sought to compare outcomes following TF T:  All TF TAVR patients (N=1416) from the randomized and non-
randomized continued access populations of the PARTNER trial were included in the analysis. The primary endpoint was vascular complications at 30 
days. Univariate and multivariate models were used to compare the differences in outcomes based on femoral access technique.
results: Surgical cutdown was performed in 857 patients and a fully percutaneous procedure in 559. The absolute frequency and adjusted odds 
of total vascular complications at 30 days was significantly lower following percutaneous access and persisted out to 1 year (Table). Patients having 
a percutaneous procedure also had greater rates of device and procedural success and shorter procedural times. Post-procedure length of stay was 
not different between the groups.
conclusions: A fully percutaneous approach to TF TAVR may be associated with a lower incidence of vascular complications compared with 
vascular access by surgical cutdown and appears to be a viable approach to TF access in TAVR despite the use of large-diameter introducer sheaths 
and catheters.
Cutdown
(N=857)
Percutaneous
(N=559)
AOR (95% CI) p-value
Vascular Complications
Total
In-hospital 20.1% 13.8% 1.54 (1.13 - 2.08) 0.0055
30-day 21.9% 14.7% 1.46 (1.12 - 1.91) 0.0048
1-year 22.5% 15.4% 1.43 (1.11 - 1.86) 0.0064
Major
In-hospital 10.7% 7.7% 0.057
30-day 11.1% 8.1% 0.06
1-year 11.4% 8.2% 0.059
Access site hematoma
In-hospital 4.3% 2.3% 0.05
30-day 6.3% 2.7% 0.003
1-year 6.5% 2.9% 0.003
Procedural Characterstics
Fluoroscopy (min) 22 [17 - 30] 24 [18 - 31] 0.0594
Time to deployment (min) 15 [9- 24] 11 [7 - 20] <0.0001
Total procedure time (min) 117 [89 - 161] 97 [76 - 125] <0.0001
Total cath lab time (min) 229 [196 - 224] 208 [180 - 244] < 0.0001
Post-TAVR LOS (days) 6 [4 - 7] 5 [4 - 6] 0.2815
Procedural success 73.5% 80.9% 0.63 (0.48 - 0.82) 0.0008
Device success 80.2% 85.5% 0.68 (0.51 - 0.92) 0.0133
